Listar por autor "Fonseca, Candida"

Mostrando ítems 1-4 de 4

    • Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry 

      Chioncel, Ovidiu; Lainscak, Mitja; Seferovic, Petar M.; Anker, Stefan; Crespo-Leiro, María Generosa; Harjola, Veli-Pekka; Parissis, John; Laroche, Cecile; Piepoli, Massimo Francesco; Fonseca, Candida; Mebazaa, Alexandre; Lund, Lars H.; Ambrosio, Giuseppe A.; Coats, Andrew J.; Ferrari, Roberto; Ruschitzka, Frank; Maggioni, Aldo P.; Filippatos, Gerasimos (Wiley, 2017-04-06)
      [Abstract] AIMS: The objectives of the present study were to describe epidemiology and outcomes in ambulatory heart failure (HF) patients stratified by left ventricular ejection fraction (LVEF) and to identify predictors ...

    • European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions 

      Crespo-Leiro, María Generosa; Anker, Stefan; Maggioni, Aldo P.; Coats, Andrew J.; Filippatos, Gerasimos; Ruschitzka, Frank; Ferrari, Roberto; Piepoli, Massimo Francesco; Delgado Jiménez, Juan Francisco; Metra, Marco; Fonseca, Candida; Hradec, Jaromir; Amir, Offer; Logeart, Damien; Dahlström, Ulf; Merkely, Bela; Drozdz, Jaroslaw; Goncalvesova, Eva; Hassanein, Mahmoud; Chioncel, Ovidiu; Lainscak, Mitja; Seferovic, Petar M.; Tousoulis, Dimitris; Kavoliunene, Ausra; Fruhwald, Friedrich; Fazlibegovic, Emir; Temizhan, Ahmet; Gatzov, Plamen; Erglis, Andrejs; Laroche, Cecile; Mebazaa, Alexandre (Wiley, 2016-06-20)
      [Abstract] AIMS: The European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT-R) was set up with the aim of describing the clinical epidemiology and the 1-year outcomes of patients with heart failure (HF) ...

    • Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use 

      Papp, Zoltán; Álvarez, Julián; Bettex, Dominique; Bouchez, Stefan; Brito, Dulce; Černý, Vladimir; Comin-Colet; Comin-Colet, Josep; Crespo-Leiro, María Generosa; Delgado-Jiménez, Juan F.; Édes, István; Eremenko, Alexander; Farmakis, Dimitrios; Fedele, Francesco; Fonseca, Candida; Fruhwald, Sonja; Girardis, Massimo; Guarracino, Fabio; Harjola, Veli-Pekka; Heringlake, Matthias; Herpain, Antoine; Heunks, Leo; Husebye, Tryggve; Ivancan, Višnja; Karason, Kristjan; Kaul, Sundeep; Kivikko, Matti; Kubica, Janek; Masip, Josep; Matskeplishvili, Simon; Mebazaa, Alexandre; Nieminen, Markku S.; Oliva, Fabrizio; Papp, Julius G.; Parissis, John; Parkhomenko, Alexander; Põder, Pentti; Pölzl, Gerhard; Reinecke, Alexander; Ricksten, Sven-Erik; Riha, Hynek; Rudiger, Alain; Sarapohja, Toni; Schwinger, Robert H. G.; Toller, Wolfgang; Tritapepe, Luigi; Tschöpe, Carsten; Wikström, Gerhard; Lewinski, Dirk von; Vrtovec, Bojan; Pollesello, Piero; Agostoni, Piergiuseppe (Wolters Kluwer, 2020-07)
      [Abstract] Levosimendan was first approved for clinical use in 2000, when authorization was granted by Swedish regulatory authorities for the hemodynamic stabilization of patients with acutely decompensated chronic heart ...

    • Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure long-term registry 

      Canepa, Marco; Fonseca, Candida; Chioncel, Ovidiu; Laroche, Cécile; Crespo-Leiro, María Generosa; Coats, Andrew J.S.; Mebazaa, Alexandre (Elsevier, 2018-06)
      [Abstract] Objectives. This study compared the performance of major heart failure (HF) risk models in predicting mortality and examined their utilization using data from a contemporary multinational registry. Background. ...